Genmab | GEN - Satış Gelirleri





Satış Değişiklik Tarih
Agios Pharmaceuticals USD 18.8M 1.17M 2026-03
Almirall EUR 602.71M 55.09M 2026-06
Amarin USD 49.22M 451K 2025-12
Amgen USD 8.62B 1.28B 2026-03
argenx SE USD 1.36B 240M 2026-06
AstraZeneca USD 15.38B 90M 2026-06
Bayer EUR 13.41B 1.97B 2026-03
BioMarin Pharmaceutical USD 766M 109M 2026-03
Demant DKK 6.25B 800M 2025-12
Exelixis USD 610.8M 12.14M 2026-03
Fresenius Medical Care EUR 4.61B 460M 2026-03
Genmab DKK 1.06B 36M 2025-12
GlaxoSmithKline GBP 8.41B 781M 2026-06
GN Store Nord DKK 3.85B 830M 2026-03
GRIFOLS EUR 1.87B 170M 2026-06
Hikma Pharmaceutical USD 1.69B 863M 2025-12
Insmed USD 305.96M 42.16M 2026-03
Lakefront Biotherapeutics EUR 6.5M 894.32M 2026-03
Lonza CHF 3.58B 63M 2025-06
Merck EUR 5.13B 120M 2026-03
Novartis USD 14.41B 1.3B 2026-06
Regeneron Pharmaceuticals USD 3.6B 280M 2026-03
Roche Holding CHF 30.36B 14.71B 2026-06
Sanofi EUR 11.24B 60M 2026-03
UCB EUR 4.25B 764M 2025-12